Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Anticancer Res. 2018 Mar;38(3):1491–1497. doi: 10.21873/anticanres.12376

Table IV.

Multivariate analysis of predictors of distant-recurrence free survival.

Variable Preoperative RT (N=49) Upfront Surgery (N=49)

Hazard Ratio (95% CI) p Value Hazard Ratio (95% CI) p Value

Age 0.99 (0.96 – 1.01) 0.27 1.01 (0.98 – 1.03) 0.61

Tumor Size 1.07 (0.98 – 1.17) 0.11 1.06 (1.00 – 1.12) 0.05

High Grade Histology 1.67 (0.48 – 5.83) 0.42 5.67 (0.68 – 46.86) 0.11

Histology
 HGUPS* 0.66 (0.19 – 2.34) 0.71 1.84 (0.53 – 6.43) 0.05
 Leiomyosarcoma 1.48 (0.01 – 107) 1.70 (0.38 – 7.49)
 Liposarcoma 0.40 (0.08 – 1.88) 0.06 (0.01 – 0.57)

Baseline CRP 0.96 (0.84 – 1.10) 0.54 1.02 (0.96 – 1.08) 0.49

Baseline N/L Ratio 1.04 (0.98 – 1.11) 0.18 1.08 (0.96 – 1.22) 0.20
*

High grade undifferentiated pleomorphic sarcoma.

C-reactive protein.